2021 annual financial data
Revelation Biosciences 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -11,950,485 USD and net income was -11,986,837 USD.
Operating cash flow was -11,090,573 USD.
Get free Revelation Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,950,485 USD
- Net income
- -11,986,837 USD
- Operating cash flow
- -11,090,573 USD